Vol 2, No 3 (2011)

Date published: 2011-10-18

Table of Contents

open access


Od Redakcji

Krzysztof Warzocha


Hematologia 2011;2(3):1-1.

Bendamustine in therapy of lymphoid malignancies

Iwona Hus, Anna Korycka-Wołowiec, Justyna Dzietczenia, Piotr Boguradzki, Tomasz Wróbel

Review paper

Hematologia 2011;2(3):220-232.

Optimizing first-line treatment of patients with chronic lymphocytic leukemia

Iwona Hus, Magdalena Górska-Kosicka, Krzysztof Warzocha

Review paper

Hematologia 2011;2(3):233-245.

The role of ofatumumab in the treatment of B-cell lymphomas

Marek Dudziński

Review paper

Hematologia 2011;2(3):246-255.

Role of maintenance therapy in the treatment of plasma cell myeloma

Krzysztof Jamroziak

Review paper

Hematologia 2011;2(3):256-265.

Evolution of the therapy strategies in hairy cell leukemia — 22 years lasting case study

Sebastian Grosicki, Jerzy Hołowiecki, Ewa Bodzenta

Case report

Hematologia 2011;2(3):284-289.

Colorectal cancers in chronic lymphocytic leukemia patients

Łukasz Bołkun, Jarosław Piszcz, Edyta Cichocka, Janusz Dzięcioł, Janusz Kłoczko

Case report

Hematologia 2011;2(3):290-293.

Secondary acute myeloid leukemia with monosomy 7 in Ph-negative cells in a patient with chronic myeloid leukemia in chronic phase

Elżbieta Patkowska, Przemysław Juszczyński, Katarzyna Borg, Iwona Solarska, Monika Prochorec-Sobieszek, Krzysztof Warzocha

Case report

Hematologia 2011;2(3):294-301.

The highlights of ASCO and EHA conferences on chronic myeloid leukemia in 2011

Joanna Góra-Tybor

Conference report / Report

Hematologia 2011;2(3):276-283.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.